# MREO (Mereo Biopharma Group PLC) - SEC EDGAR Financial Statements

> Mereo Biopharma Group PLC reported $500K in revenue and a net loss of $26.94M for the fiscal year ended December 31, 2025, with a -6080.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/MREO
- Markdown: https://convexityos.com/fundamentals/MREO.md
- SEC CIK: 0001719714
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001719714&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $500K | Dec 31, 2025 |
| Operating Income | FY 2025 | -$30.40M | -6080.8% margin |
| Net Income | FY 2025 | -$26.94M | -5387.6% net margin |
| Diluted EPS | FY 2025 | -$0.03 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$22.09M | -4417.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $26.10M | Total debt: $577K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $500K | $0 | $10.00M | $0 |
| Research & Development | $17.77M | $20.93M | $17.42M | $29.46M |
| **Operating Income** | -$40.11M | -$47.36M | -$28.42M | -$54.43M |
| **EBITDA** | -$39.48M | -$46.78M | -$27.85M | -$54.24M |
| Interest Income | $2.17M | $3.04M | $2.13M | $840K |
| Interest Expense | $255K | $1.37M | $2.88M | $4.17M |
| Income Before Tax | -$41.88M | -$43.25M | -$30.00M | -$42.94M |
| Income Tax Expense | $0 | $0 | -$532K | -$718K |
| **Net Income** | -$41.88M | -$43.25M | -$29.47M | -$42.22M |
| Basic EPS | -$0.05 | -$0.06 | -$0.04 | -$0.07 |
| **Diluted EPS** | -$0.05 | -$0.06 | -$0.04 | -$0.07 |
| Basic Shares Outstanding | 797.1M | 739.6M | 659.5M | 603.2M |
| Diluted Shares Outstanding | 797.1M | 739.6M | 659.5M | 603.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $800K | $0 | -- | -- | $0 | $500K | -- | $0 |
| Research & Development | $2.09M | $1.81M | $4.75M | $4.19M | $4.27M | $5.37M | $3.93M | $8.82M |
| **Operating Income** | -$6.22M | -$7.03M | -$8.77M | -$8.39M | -$10.02M | -$10.50M | -$11.20M | -$15.28M |
| **EBITDA** | -$6.06M | -$6.87M | -$8.60M | -$7.93M | -$10.16M | -$10.34M | -$11.06M | -$15.13M |
| Interest Income | $241K | $278K | $327K | $421K | $504K | $589K | $659K | $881K |
| Interest Expense | $10K | $16K | $20K | $23K | $28K | $24K | $180K | $375K |
| Income Before Tax | -$5.86M | -$7.00M | -$6.72M | -$7.35M | -$7.02M | -$14.62M | -$12.89M | -$7.05M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$5.86M | -$7.00M | -$6.72M | -$7.35M | -$7.02M | -$14.62M | -$12.89M | -$7.05M |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | -$0.02 | -$0.02 | -- |
| **Diluted EPS** | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | -$0.02 | -$0.02 | -- |
| Basic Shares Outstanding | 804.5M | 803.6M | 801.8M | -- | 799.9M | 799.4M | 784.3M | -- |
| Diluted Shares Outstanding | 804.5M | 803.6M | 801.8M | -- | 799.9M | 799.4M | 784.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $40.99M | $69.80M | $57.42M | $68.18M |
| **Cash & Short-Term Investments** | $40.99M | $69.80M | $57.42M | $68.18M |
| **Total Current Assets** | $45.02M | $74.76M | $63.76M | $75.20M |
| Property, Plant & Equipment, Net | $137K | $257K | $405K | $551K |
| Intangible Assets | $516K | $643K | $1.09M | $0 |
| **Total Non-Current Assets** | $897K | $1.63M | $2.74M | $2.22M |
| **Total Assets** | $45.92M | $76.39M | $66.50M | $77.41M |
| Accounts Payable | $1.33M | $2.44M | $2.35M | $3.49M |
| Deferred Revenue (Current) | $0 | -- | -- | -- |
| Other Current Liabilities | $741K | $1.09M | $1.02M | $1.07M |
| **Total Current Liabilities** | $4.30M | $13.85M | $9.49M | $24.38M |
| Other Non-Current Liabilities | $661K | $565K | $764K | $0 |
| **Total Non-Current Liabilities** | $699K | $1.57M | $6.48M | $1.64M |
| **Total Liabilities** | $5.00M | $15.42M | $15.96M | $26.01M |
| **Total Debt (incl. Leases)** | $202K | $894K | $1.56M | $2.04M |
| Common Stock | $3.13M | $3.06M | $2.77M | $2.48M |
| Retained Earnings | -$501.0M | -$462.9M | -$419.6M | -$404.6M |
| Accumulated Other Comp. Income | -$10.82M | -$18.85M | -$17.48M | -$21.69M |
| **Total Stockholders' Equity** | $40.92M | $60.97M | $50.54M | $51.40M |
| Total Equity | $40.92M | $60.97M | $50.54M | $51.40M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $26.10M | $30.12M | $30.10M | $40.99M | $48.70M | $56.12M | $62.48M | $69.80M |
| **Cash & Short-Term Investments** | $26.10M | $30.12M | $30.10M | $40.99M | $48.70M | $56.12M | $62.48M | $69.80M |
| **Total Current Assets** | $28.67M | $33.40M | $40.03M | $45.02M | $52.41M | $61.42M | $66.90M | $74.76M |
| Property, Plant & Equipment, Net | $24K | $54K | $91K | $137K | $174K | $218K | $247K | $257K |
| Intangible Assets | $129K | $256K | $381K | $516K | $643K | $470K | $554K | $643K |
| **Total Non-Current Assets** | $911K | $1.31M | $580K | $897K | $1.20M | $1.21M | $1.42M | $1.63M |
| **Total Assets** | $29.58M | $34.71M | $40.61M | $45.92M | $53.60M | $62.63M | $68.32M | $76.39M |
| Accounts Payable | $1.00M | $1.12M | $3.23M | $1.33M | $879K | $1.14M | $2.92M | $2.44M |
| Deferred Revenue (Current) | $200K | -- | -- | $0 | -- | -- | -- | -- |
| Other Current Liabilities | $888K | $1.07M | $905K | $741K | $622K | $777K | $894K | $1.09M |
| **Total Current Liabilities** | $5.49M | $5.68M | $6.18M | $4.30M | $6.02M | $7.56M | $7.50M | $13.85M |
| Other Non-Current Liabilities | $370K | $370K | $362K | $661K | $652K | $352K | $325K | $565K |
| **Total Non-Current Liabilities** | $378K | $385K | $383K | $699K | $988K | $897K | $744K | $1.57M |
| **Total Liabilities** | $5.87M | $6.06M | $6.56M | $5.00M | $7.00M | $8.45M | $8.24M | $15.42M |
| **Total Debt (incl. Leases)** | $577K | $1.03M | -- | $202K | $397K | $601K | $747K | $894K |
| Common Stock | $3.15M | $3.15M | $3.15M | $3.13M | $3.13M | $3.13M | $3.13M | $3.06M |
| Retained Earnings | -$520.4M | -$514.5M | -$507.5M | -$501.0M | -$493.7M | -$486.6M | -$472.0M | -$462.9M |
| Accumulated Other Comp. Income | -$12.27M | -$12.29M | -$12.57M | -$10.82M | -$10.91M | -$8.64M | -$15.29M | -$18.85M |
| **Total Stockholders' Equity** | $23.71M | $28.65M | $34.05M | $40.92M | $46.60M | $54.18M | $60.08M | $60.97M |
| Total Equity | $23.71M | $28.65M | $34.05M | $40.92M | $46.60M | $54.18M | $60.08M | $60.97M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$41.88M | -$43.25M | -$29.47M | -$42.22M |
| Depreciation & Amortization | $622K | $581K | $566K | $181K |
| Stock-Based Compensation | $7.60M | $7.39M | $4.92M | $4.77M |
| Change in Payables | -$1.38M | $146K | -$1.26M | $617K |
| **Operating Cash Flow** | -$30.97M | -$32.83M | -$21.13M | -$48.82M |
| Capital Expenditure | -$20K | $0 | $0 | -$13K |
| **Free Cash Flow** | -$30.99M | -$32.83M | -$21.13M | -$48.83M |
| **Investing Cash Flow** | -$20K | -$699K | -$419K | $1.99M |
| Common Stock Issued | $39K | $47.00M | $11.61M | $0 |
| **Financing Cash Flow** | $327K | $46.15M | $7.97M | $200K |
| **Net Change in Cash** | -$30.66M | $12.38M | -$10.76M | -$46.63M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.86M | -$7.00M | -$6.72M | -$7.35M | -$7.02M | -$14.62M | -$12.89M | -$7.05M |
| Depreciation & Amortization | $159K | $165K | $171K | $460K | -$144K | $162K | $144K | $148K |
| Stock-Based Compensation | $909K | $1.32M | $1.60M | $1.54M | $1.71M | $2.06M | $2.28M | $1.51M |
| Change in Payables | -$118K | -$2.14M | $1.96M | $447K | -$236K | -$1.95M | $362K | $843K |
| **Operating Cash Flow** | -$4.05M | -$6.04M | -$4.31M | -$7.68M | -$7.31M | -$7.65M | -$8.33M | -$9.42M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -$20K | $0 |
| **Free Cash Flow** | -$4.05M | -$6.04M | -$4.31M | -$7.68M | -$7.31M | -$7.65M | -$8.35M | -$9.42M |
| **Investing Cash Flow** | $0 | $0 | -$300K | $0 | $300K | $0 | -$320K | $0 |
| **Financing Cash Flow** | $0 | $0 | $0 | $39K | $0 | -$134K | $422K | -$40K |
| **Net Change in Cash** | -$4.05M | -$6.04M | -$4.61M | -$7.64M | -$7.01M | -$7.79M | -$8.23M | -$9.46M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Operating Margin** | -8021.4% | -- | -284.2% | -- |
| **Net Profit Margin** | -8375.6% | -- | -294.7% | -- |
| Return on Equity (ROE) | -102.4% | -70.9% | -58.3% | -82.1% |
| Return on Assets (ROA) | -91.2% | -56.6% | -44.3% | -54.5% |
| Current Ratio | 10.46x | 5.40x | 6.72x | 3.09x |
| Quick Ratio | 9.53x | 5.04x | 6.05x | 2.80x |
| Debt to Equity | 0.00x | 0.01x | 0.03x | 0.04x |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -113.6% | -98.1% | -104.9% | -102.4% | -89.2% | -91.5% | -78.5% | -70.9% |
| Return on Assets (ROA) | -91.1% | -80.9% | -87.9% | -91.2% | -77.6% | -79.1% | -69.1% | -56.6% |
| Current Ratio | 5.22x | 5.88x | 6.48x | 10.46x | 8.71x | 8.13x | 8.92x | 5.40x |
| Quick Ratio | 4.75x | 5.31x | 4.87x | 9.53x | 8.09x | 7.43x | 8.33x | 5.04x |
| Debt to Equity | 0.02x | 0.04x | -- | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -- | -- | -- | -- | -100.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
